Evaluation of the IMMULITE HBsAg assay using commercially available seroconversion and performance panels.

被引：0
|
作者：
Cervantes, C [1 ]
Schutzbank, TE [1 ]
Hovanec-Burns, D [1 ]
Ghadessi, M [1 ]
El Shami, AS [1 ]
机构：
[1] Diagnost Prod Corp, Los Angeles, CA USA
来源：
CLINICAL CHEMISTRY | 1998年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
6
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [41] PERFORMANCE EVALUATION OF A COMMERCIALLY AVAILABLE DESICCANT-BASED SEED DRYING SYSTEM
    Dien, Alice
    Momin, Md Abdul
    Ying, Tianyu
    Spang, Edward S.
    Kornbluth, Kurt
    Donis-Gonzalez, Irwin R.
    [J]. JOURNAL OF THE ASABE, 2022, 65 (03): : 633 - 643
  • [42] Performance evaluation of 3 commercially available qunatitative HCV tests in the clinical setting
    Roudiere, L.
    Ottomani, L.
    Mondain, A. -M.
    Perney, P.
    Blanc, F.
    Larrey, D.
    Ducos, J.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S196 - S197
  • [43] Clinical Evaluation of a Commercially Available Assay for Quantification of BCR/ABL1 Fusion Transcripts
    Woolworth, J. A.
    Church, K. G.
    Cremona, M. L.
    Aggarwal, V. S.
    Wolff, D. J.
    Nolte, F. S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 657 - 657
  • [44] Evaluation of a commercially available serologic assay for antibodies against tuberculosis-associated glycolipid antigen
    Iinuma, Y
    Senda, K
    Takakura, S
    Ichiyama, S
    Tano, M
    Abe, T
    Yamamoto, T
    Nakashima, K
    Baba, H
    Hasegawa, Y
    Shimokata, K
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (08) : 832 - 836
  • [45] Evaluation of a commercially available enzyme-linked immunosorbent assay for the diagnosis of canine sarcoptic mange
    Curtis, CF
    [J]. VETERINARY RECORD, 2001, 148 (08) : 238 - 239
  • [46] Performance Evaluation of the Ultrasensitive IMMULITE® 2000 PSA Assay with Equimolarity Up to 100 ng/mL
    Wen, J.
    Phung, T.
    IV, J.
    Garcia, Z.
    Han, A.
    Sinha, S.
    Mandap, J.
    Rouhani, R.
    Jaggi, K.
    Sahakian, N.
    Wilson, K.
    Heiermann, M.
    Lei, J.
    Sustarsic, D.
    [J]. CLINICAL CHEMISTRY, 2009, 55 (06) : A122 - A122
  • [47] The western immunoblot for Lyme disease: Determination of sensitivity, specificity, and interpretive criteria with use of commercially available performance panels
    Tilton, RC
    Sand, MN
    Manak, M
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 25 : S31 - S34
  • [48] In vitro evaluation of the impact of gastrointestinal transfer on luminal performance of commercially available products of posaconazole and itraconazole using BioGIT
    Kourentas, Alexandros
    Vertzoni, Maria
    Symillides, Mira
    Hens, Bart
    Brouwers, Joachim
    Augustijns, Patrick
    Reppas, Christos
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 515 (1-2) : 352 - 358
  • [49] Determination of tumor mutational burden using FFPE material: Content and performance comparison of different gene panels.
    Endris, Volker
    Buchhalter, Ivo
    Allgauer, Michael
    Kirchner, Martina
    Leichsenring, Jonas
    Volckmar, Anna-Lena
    Stoegbauer, Fabian
    Horak, Peter
    Kreutzfeld, Simon
    Glimm, Hanno
    Froehling, Stefan
    Neumann, Olaf
    Penzel, Roland
    Schirmacher, Peter
    Stenzinger, Albrecht
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Evaluation of the performance of the IMMULITE® 2000 Rubella IgM assay for detection of IgM antibodies to rubella virus.
    Hovanec-Burns, D
    Cervantes, C
    Gonzalez, R
    El Shami, AS
    [J]. CLINICAL CHEMISTRY, 2000, 46 (06) : A55 - A55
12345